Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Graying hair happens due to aging and might be delayed by new treatments.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.